4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with Asthma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Galli, SJ; Mukai, K; Tsai, M; Yu, M | 1 |
Jull, BA; Plummer, HK; Schuller, HM | 1 |
1 review(s) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and Asthma
Article | Year |
---|---|
Receptor-mediated effects of nicotine and its nitrosated derivative NNK on pulmonary neuroendocrine cells.
Topics: Animals; Asthma; Carbon Dioxide; Carcinogens; Carcinoma, Small Cell; Epithelial Cells; Humans; Lung; Neurosecretory Systems; Nicotine; Nitrosamines; Receptors, Nicotinic; Serotonin | 2003 |
1 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and Asthma
Article | Year |
---|---|
Thirdhand smoke component can exacerbate a mouse asthma model through mast cells.
Topics: Administration, Intranasal; Allergens; alpha7 Nicotinic Acetylcholine Receptor; Animals; Asthma; Cockroaches; Cytokines; Disease Models, Animal; Female; Lung; Mast Cells; Mice, Inbred C57BL; Mice, Transgenic; Nitrosamines; Ovalbumin; Skin; Smoke; Tobacco Smoke Pollution | 2018 |